Shopping Cart
- Remove All
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $297 | In Stock | |
5 mg | $786 | In Stock | |
10 mg | $1,180 | In Stock | |
25 mg | $1,980 | In Stock | |
50 mg | $2,890 | In Stock | |
100 mg | $4,130 | In Stock |
Description | RMC-6236 is a RAS(ON)MULTI inhibitor with anticancer activity and is used in the study of advanced malignant solid tumors and colorectal cancer. |
In vitro | METHODS: HPAC and Capan-2 cell lines were treated with RMC-6236 (1, 3, 10, 30nM, 4h), and time and concentration-dependent changes in RAS pathway signaling markers pERK, pAKT and pS6 were observed.
RESULTS: Time- and concentration-dependent inhibition of RAS pathway signaling markers pERK, pAKT, and pS6 was observed, with sustained inhibition of pERK and pS6 in Capan-2 cells up to at least 48 h. HPAC cells also exhibited sustained pERK inhibition and time-dependent induction of apoptosis.[2] |
In vivo | METHODS: Capan-2 (KRASG12V/WT, PDAC) and NCI-H441 (KRASG12V/WT, NSCLC) xenografted homozygous BALB/c nude mice were treated with RMC-6236 (3, 10, or 25 mg/kg, orally once a day), and blood and tumors were collected at indicated time points.
RESULTS: At the 25 mg/kg dose, RMC-6236 was able to maintain more than 80% inhibition of tumor pERK levels within 24 hours of administration; at the 10 mg/kg dose, RMC-6236 caused modest tumor regression in the sensitive model and led to 13% and 29% mean tumor regression in the Capan-2 and NCI-H441 models.[2] |
Alias | RMC6236 |
Molecular Weight | 811.05 |
Formula | C44H58N8O5S |
Cas No. | 2765081-21-6 |
Storage | store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (246.59 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.